Share Price and Basic Stock Data
Last Updated: October 10, 2025, 8:53 pm
| PEG Ratio | 2.30 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Emami Ltd operates in the personal care industry, focusing on beauty and wellness products. As of the latest data, the company’s stock price stands at ₹552, with a market capitalization of ₹24,088 Cr. Emami has demonstrated consistent revenue growth over recent quarters, with sales reaching ₹996 Cr in December 2023, up from ₹814 Cr in September 2022. However, a slight dip to ₹891 Cr was noted in March 2024, followed by a recovery to ₹906 Cr in June 2024. This fluctuation indicates a resilient demand for its products, despite seasonal variations. The annual sales figures have also shown an upward trend, increasing from ₹3,192 Cr in March 2022 to an expected ₹3,809 Cr in March 2025, reflecting a compound annual growth rate (CAGR) of approximately 9.55% over this period.
Profitability and Efficiency Metrics
Emami Ltd showcases strong profitability metrics, with an operating profit margin (OPM) of 23% as of the latest reporting period. The company’s net profit reached ₹803 Cr, translating to a net profit margin of 20.34% for March 2024, which is above the industry average of around 15-18% for personal care companies in India. The return on equity (ROE) stands impressively at 30.2%, while the return on capital employed (ROCE) is 32.4%, indicating efficient capital utilization and high profitability. Furthermore, the interest coverage ratio (ICR) of 99.86x demonstrates Emami’s robust ability to meet its interest obligations, suggesting low financial risk. However, the cash conversion cycle (CCC) of 4 days could be improved, as it indicates that the company is slower in converting its inventory and receivables into cash compared to some peers.
Balance Sheet Strength and Financial Ratios
Emami Ltd maintains a solid balance sheet, with total reserves amounting to ₹2,651 Cr against borrowings of only ₹90 Cr, resulting in a low debt-to-equity ratio of 0.02. This conservative leverage strategy enhances financial stability and reduces risk, especially in volatile market conditions. The company’s equity capital remains steady at ₹44 Cr since March 2022, supporting its strong reserve position. The price-to-book value (P/BV) ratio is 7.55x, indicating a premium valuation compared to the sector average of around 5-6x, which may reflect investor confidence in future growth prospects. Additionally, the current ratio of 1.87 and quick ratio of 1.44 indicate adequate liquidity to cover short-term liabilities, further strengthening its financial position.
Shareholding Pattern and Investor Confidence
The shareholding structure of Emami Ltd reveals a stable composition, with promoters holding 54.84% of the equity, suggesting strong control and commitment to the company’s long-term vision. Foreign institutional investors (FIIs) account for 11.89%, while domestic institutional investors (DIIs) hold 24.06%. This distribution indicates a balanced mix of domestic and foreign investment, reflecting confidence among institutional investors in Emami’s growth trajectory. Notably, the number of shareholders increased from 85,460 in September 2022 to 1,26,599 by June 2025, highlighting growing retail investor interest. This positive sentiment is further bolstered by the company’s consistent dividend payout ratio, which is set at 54% for March 2025, indicating a commitment to shareholder returns.
Outlook, Risks, and Final Insight
Looking ahead, Emami Ltd is well-positioned for continued growth, driven by its strong brand portfolio and expanding market presence in the personal care sector. However, potential risks include fluctuating raw material costs and intense competition from both domestic and international players, which could pressure margins. Additionally, the company’s dependency on the Indian market may expose it to domestic economic fluctuations. Despite these challenges, Emami’s robust financial health, efficient operations, and loyal customer base suggest a balanced outlook. The expected growth in revenue and profitability, combined with a low debt profile, positions Emami for sustainable long-term growth, making it an attractive option for investors seeking exposure to the personal care industry in India.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Emami Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Honasa Consumer Ltd | 9,351 Cr. | 288 | 434/190 | 131 | 36.9 | 0.00 % | 7.44 % | 5.51 % | 10.0 |
| Ambica Agarbathies Aroma & Industries Ltd | 43.0 Cr. | 25.0 | 37.0/24.0 | 84.3 | 63.6 | 0.00 % | 7.49 % | 0.45 % | 10.0 |
| Ador Multi Products Ltd | 94.8 Cr. | 99.1 | 119/23.4 | 19.4 | 0.00 % | 11.4 % | 3.09 % | 10.0 | |
| Kaya Ltd | 671 Cr. | 432 | 488/204 | 106 | 0.00 % | 2.50 % | % | 10.0 | |
| Jyothy Labs Ltd | 11,398 Cr. | 310 | 549/268 | 31.2 | 55.8 | 1.13 % | 24.6 % | 19.0 % | 1.00 |
| Industry Average | 78,948.77 Cr | 2,094.09 | 61.58 | 107.49 | 0.72% | 29.21% | 23.91% | 4.94 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 773 | 814 | 983 | 836 | 826 | 865 | 996 | 891 | 906 | 891 | 1,049 | 963 | 904 |
| Expenses | 604 | 621 | 689 | 636 | 636 | 632 | 682 | 682 | 692 | 645 | 715 | 744 | 692 |
| Operating Profit | 169 | 193 | 294 | 199 | 190 | 233 | 314 | 209 | 214 | 246 | 334 | 219 | 212 |
| OPM % | 22% | 24% | 30% | 24% | 23% | 27% | 32% | 24% | 24% | 28% | 32% | 23% | 23% |
| Other Income | 6 | 42 | 7 | 14 | 8 | 11 | 11 | 11 | 10 | 22 | 15 | 21 | 22 |
| Interest | 2 | 2 | 2 | 1 | 2 | 2 | 3 | 3 | 2 | 2 | 2 | 3 | 2 |
| Depreciation | 88 | 48 | 47 | 64 | 46 | 46 | 46 | 48 | 44 | 45 | 46 | 44 | 44 |
| Profit before tax | 85 | 186 | 251 | 148 | 150 | 196 | 276 | 169 | 178 | 220 | 301 | 194 | 187 |
| Tax % | 14% | 3% | 7% | 4% | 9% | 8% | 6% | 13% | 16% | 4% | 7% | 16% | 12% |
| Net Profit | 73 | 180 | 233 | 142 | 137 | 180 | 261 | 147 | 151 | 211 | 279 | 162 | 164 |
| EPS in Rs | 1.67 | 4.17 | 5.38 | 3.27 | 3.14 | 4.09 | 5.92 | 3.41 | 3.50 | 4.87 | 6.39 | 3.72 | 3.76 |
Last Updated: August 1, 2025, 9:50 pm
Below is a detailed analysis of the quarterly data for Emami Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 904.00 Cr.. The value appears to be declining and may need further review. It has decreased from 963.00 Cr. (Mar 2025) to 904.00 Cr., marking a decrease of 59.00 Cr..
- For Expenses, as of Jun 2025, the value is 692.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 744.00 Cr. (Mar 2025) to 692.00 Cr., marking a decrease of 52.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 212.00 Cr.. The value appears to be declining and may need further review. It has decreased from 219.00 Cr. (Mar 2025) to 212.00 Cr., marking a decrease of 7.00 Cr..
- For OPM %, as of Jun 2025, the value is 23.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 23.00%.
- For Other Income, as of Jun 2025, the value is 22.00 Cr.. The value appears strong and on an upward trend. It has increased from 21.00 Cr. (Mar 2025) to 22.00 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Jun 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 44.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 44.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 187.00 Cr.. The value appears to be declining and may need further review. It has decreased from 194.00 Cr. (Mar 2025) to 187.00 Cr., marking a decrease of 7.00 Cr..
- For Tax %, as of Jun 2025, the value is 12.00%. The value appears to be improving (decreasing) as expected. It has decreased from 16.00% (Mar 2025) to 12.00%, marking a decrease of 4.00%.
- For Net Profit, as of Jun 2025, the value is 164.00 Cr.. The value appears strong and on an upward trend. It has increased from 162.00 Cr. (Mar 2025) to 164.00 Cr., marking an increase of 2.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 3.76. The value appears strong and on an upward trend. It has increased from 3.72 (Mar 2025) to 3.76, marking an increase of 0.04.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 5:38 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,700 | 2,076 | 2,358 | 2,488 | 2,531 | 2,695 | 2,655 | 2,881 | 3,192 | 3,406 | 3,578 | 3,809 |
| Expenses | 1,255 | 1,536 | 1,670 | 1,729 | 1,812 | 1,970 | 1,970 | 2,000 | 2,254 | 2,550 | 2,632 | 2,796 |
| Operating Profit | 445 | 541 | 688 | 759 | 719 | 725 | 685 | 880 | 938 | 855 | 946 | 1,013 |
| OPM % | 26% | 26% | 29% | 31% | 28% | 27% | 26% | 31% | 29% | 25% | 26% | 27% |
| Other Income | 53 | 91 | 44 | 31 | 19 | 25 | 46 | 69 | 90 | 69 | 41 | 68 |
| Interest | 5 | 5 | 54 | 58 | 34 | 21 | 21 | 13 | 5 | 7 | 10 | 9 |
| Depreciation | 35 | 34 | 255 | 309 | 311 | 325 | 336 | 367 | 335 | 247 | 186 | 178 |
| Profit before tax | 457 | 592 | 423 | 424 | 393 | 403 | 374 | 569 | 688 | 670 | 791 | 894 |
| Tax % | 12% | 18% | 14% | 20% | 22% | 25% | 19% | 20% | -22% | 6% | 8% | 10% |
| Net Profit | 402 | 485 | 363 | 340 | 306 | 303 | 302 | 455 | 837 | 627 | 724 | 803 |
| EPS in Rs | 8.87 | 10.70 | 8.00 | 7.50 | 6.77 | 6.68 | 6.67 | 10.23 | 19.02 | 14.50 | 16.58 | 18.48 |
| Dividend Payout % | 39% | 33% | 44% | 47% | 52% | 60% | 60% | 78% | 42% | 55% | 48% | 54% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 20.65% | -25.15% | -6.34% | -10.00% | -0.98% | -0.33% | 50.66% | 83.96% | -25.09% | 15.47% | 10.91% |
| Change in YoY Net Profit Growth (%) | 0.00% | -45.80% | 18.82% | -3.66% | 9.02% | 0.65% | 50.99% | 33.29% | -109.05% | 40.56% | -4.56% |
Emami Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 7% |
| 3 Years: | 6% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 21% |
| 3 Years: | -1% |
| TTM: | 10% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 11% |
| 3 Years: | 8% |
| 1 Year: | -26% |
| Return on Equity | |
|---|---|
| 10 Years: | 26% |
| 5 Years: | 31% |
| 3 Years: | 30% |
| Last Year: | 30% |
Last Updated: September 5, 2025, 3:30 am
Balance Sheet
Last Updated: October 10, 2025, 1:58 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 23 | 23 | 23 | 23 | 23 | 45 | 45 | 44 | 44 | 44 | 44 | 44 |
| Reserves | 909 | 1,208 | 1,589 | 1,732 | 1,991 | 2,031 | 1,778 | 1,718 | 2,032 | 2,259 | 2,403 | 2,651 |
| Borrowings | 38 | 36 | 671 | 473 | 326 | 110 | 210 | 101 | 282 | 91 | 94 | 90 |
| Other Liabilities | 333 | 410 | 409 | 376 | 458 | 633 | 644 | 656 | 692 | 703 | 728 | 741 |
| Total Liabilities | 1,302 | 1,676 | 2,692 | 2,603 | 2,798 | 2,819 | 2,678 | 2,520 | 3,050 | 3,096 | 3,269 | 3,525 |
| Fixed Assets | 396 | 453 | 1,918 | 1,994 | 1,802 | 1,680 | 1,459 | 1,132 | 1,344 | 1,245 | 1,114 | 984 |
| CWIP | 12 | 29 | 67 | 22 | 30 | 36 | 8 | 6 | 3 | 6 | 8 | 15 |
| Investments | 296 | 501 | 104 | 128 | 314 | 187 | 156 | 255 | 303 | 293 | 442 | 676 |
| Other Assets | 599 | 693 | 604 | 460 | 652 | 915 | 1,055 | 1,126 | 1,400 | 1,551 | 1,706 | 1,850 |
| Total Assets | 1,302 | 1,676 | 2,692 | 2,603 | 2,798 | 2,819 | 2,678 | 2,520 | 3,050 | 3,096 | 3,269 | 3,525 |
Below is a detailed analysis of the balance sheet data for Emami Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 44.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 44.00 Cr..
- For Reserves, as of Mar 2025, the value is 2,651.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,403.00 Cr. (Mar 2024) to 2,651.00 Cr., marking an increase of 248.00 Cr..
- For Borrowings, as of Mar 2025, the value is 90.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 94.00 Cr. (Mar 2024) to 90.00 Cr., marking a decrease of 4.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 741.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 728.00 Cr. (Mar 2024) to 741.00 Cr., marking an increase of 13.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 3,525.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,269.00 Cr. (Mar 2024) to 3,525.00 Cr., marking an increase of 256.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 984.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,114.00 Cr. (Mar 2024) to 984.00 Cr., marking a decrease of 130.00 Cr..
- For CWIP, as of Mar 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2024) to 15.00 Cr., marking an increase of 7.00 Cr..
- For Investments, as of Mar 2025, the value is 676.00 Cr.. The value appears strong and on an upward trend. It has increased from 442.00 Cr. (Mar 2024) to 676.00 Cr., marking an increase of 234.00 Cr..
- For Other Assets, as of Mar 2025, the value is 1,850.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,706.00 Cr. (Mar 2024) to 1,850.00 Cr., marking an increase of 144.00 Cr..
- For Total Assets, as of Mar 2025, the value is 3,525.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,269.00 Cr. (Mar 2024) to 3,525.00 Cr., marking an increase of 256.00 Cr..
Notably, the Reserves (2,651.00 Cr.) exceed the Borrowings (90.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 407.00 | 505.00 | 17.00 | 286.00 | 393.00 | 615.00 | 475.00 | 779.00 | 656.00 | 764.00 | 852.00 | -89.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 17 | 18 | 20 | 14 | 22 | 29 | 42 | 29 | 37 | 44 | 50 | 43 |
| Inventory Days | 76 | 59 | 68 | 83 | 87 | 88 | 102 | 118 | 121 | 100 | 102 | 94 |
| Days Payable | 77 | 90 | 112 | 85 | 109 | 115 | 135 | 138 | 138 | 124 | 143 | 133 |
| Cash Conversion Cycle | 16 | -13 | -24 | 12 | 1 | 2 | 9 | 10 | 19 | 20 | 9 | 4 |
| Working Capital Days | -7 | -16 | -54 | -62 | -32 | -6 | 7 | -3 | 0 | 28 | 30 | 25 |
| ROCE % | 50% | 61% | 30% | 23% | 22% | 19% | 18% | 29% | 31% | 28% | 32% | 32% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Kotak Emerging Equity Fund - Regular Plan | 8,135,375 | 1.13 | 508.87 | 8,135,375 | 2025-04-22 17:25:36 | 0% |
| HDFC Mid-Cap Opportunities Fund - Regular Plan | 7,419,485 | 0.71 | 464.09 | 7,419,485 | 2025-04-22 13:31:13 | 0% |
| Nippon India Small Cap Fund | 7,360,252 | 0.89 | 460.38 | 7,360,252 | 2025-04-22 17:25:36 | 0% |
| SBI Large & Midcap Fund | 6,500,000 | 1.73 | 406.58 | 6,500,000 | 2025-04-22 15:56:58 | 0% |
| DSP Mid Cap Fund | 5,265,742 | 1.86 | 329.37 | 5,265,742 | 2025-04-22 15:56:58 | 0% |
| DSP ELSS Tax Saver Fund | 4,224,369 | 1.74 | 264.23 | 4,224,369 | 2025-04-22 17:25:36 | 0% |
| Franklin India Prima Fund | 3,676,225 | 2.09 | 229.95 | 3,676,225 | 2025-04-22 15:56:58 | 0% |
| HDFC Small Cap Fund - Regular Plan | 3,365,892 | 0.72 | 210.54 | 3,365,892 | 2025-04-22 15:56:58 | 0% |
| DSP Equity Opportunities Fund | 2,906,650 | 1.52 | 181.81 | 2,906,650 | 2025-04-22 17:25:36 | 0% |
| Franklin India Smaller Companies Fund | 2,750,000 | 1.34 | 172.01 | 2,750,000 | 2025-04-22 02:06:43 | 0% |
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 16.55 | 14.50 | 18.88 | 10.23 | 6.67 |
| Diluted EPS (Rs.) | 16.55 | 14.50 | 18.88 | 10.23 | 6.67 |
| Cash EPS (Rs.) | 20.93 | 20.00 | 26.88 | 18.58 | 14.23 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 56.30 | 52.43 | 47.02 | 39.63 | 40.22 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 56.30 | 52.43 | 47.02 | 39.63 | 40.22 |
| Revenue From Operations / Share (Rs.) | 81.97 | 77.20 | 72.36 | 64.80 | 58.58 |
| PBDIT / Share (Rs.) | 22.83 | 21.12 | 23.75 | 21.45 | 16.50 |
| PBIT / Share (Rs.) | 18.57 | 15.51 | 16.16 | 13.19 | 9.08 |
| PBT / Share (Rs.) | 18.20 | 15.35 | 15.93 | 12.89 | 8.38 |
| Net Profit / Share (Rs.) | 16.67 | 14.39 | 19.30 | 10.32 | 6.80 |
| NP After MI And SOA / Share (Rs.) | 16.58 | 14.50 | 19.02 | 10.23 | 6.68 |
| PBDIT Margin (%) | 27.84 | 27.35 | 32.81 | 33.09 | 28.16 |
| PBIT Margin (%) | 22.64 | 20.09 | 22.33 | 20.35 | 15.49 |
| PBT Margin (%) | 22.20 | 19.87 | 22.01 | 19.89 | 14.29 |
| Net Profit Margin (%) | 20.34 | 18.64 | 26.66 | 15.93 | 11.61 |
| NP After MI And SOA Margin (%) | 20.22 | 18.77 | 26.28 | 15.78 | 11.40 |
| Return on Networth / Equity (%) | 29.57 | 27.77 | 40.40 | 25.79 | 16.60 |
| Return on Capital Employeed (%) | 32.14 | 28.68 | 33.28 | 32.22 | 21.80 |
| Return On Assets (%) | 22.06 | 20.56 | 27.44 | 18.04 | 11.30 |
| Total Debt / Equity (X) | 0.02 | 0.03 | 0.12 | 0.05 | 0.11 |
| Asset Turnover Ratio (%) | 1.12 | 1.00 | 1.07 | 1.04 | 0.90 |
| Current Ratio (X) | 1.87 | 1.78 | 1.17 | 1.61 | 1.30 |
| Quick Ratio (X) | 1.44 | 1.32 | 0.78 | 1.18 | 0.99 |
| Inventory Turnover Ratio (X) | 2.36 | 2.43 | 2.72 | 2.65 | 3.17 |
| Dividend Payout Ratio (NP) (%) | 48.26 | 55.18 | 42.38 | 78.20 | 119.88 |
| Dividend Payout Ratio (CP) (%) | 38.39 | 39.79 | 30.29 | 43.27 | 56.80 |
| Earning Retention Ratio (%) | 51.74 | 44.82 | 57.62 | 21.80 | -19.88 |
| Cash Earning Retention Ratio (%) | 61.61 | 60.21 | 69.71 | 56.73 | 43.20 |
| Interest Coverage Ratio (X) | 99.86 | 126.05 | 206.51 | 71.83 | 35.58 |
| Interest Coverage Ratio (Post Tax) (X) | 74.54 | 86.90 | 169.83 | 35.58 | 16.18 |
| Enterprise Value (Cr.) | 18339.38 | 0.00 | 19900.10 | 21407.37 | 7794.39 |
| EV / Net Operating Revenue (X) | 5.13 | 0.00 | 6.23 | 7.43 | 2.94 |
| EV / EBITDA (X) | 18.41 | 0.00 | 19.00 | 22.46 | 10.43 |
| MarketCap / Net Operating Revenue (X) | 5.16 | 0.00 | 6.19 | 7.53 | 2.90 |
| Retention Ratios (%) | 51.73 | 44.81 | 57.61 | 21.79 | -19.88 |
| Price / BV (X) | 7.55 | 0.00 | 9.51 | 12.30 | 4.22 |
| Price / Net Operating Revenue (X) | 5.16 | 0.00 | 6.19 | 7.53 | 2.90 |
| EarningsYield | 0.03 | 0.00 | 0.04 | 0.02 | 0.03 |
After reviewing the key financial ratios for Emami Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 16.55. This value is within the healthy range. It has increased from 14.50 (Mar 23) to 16.55, marking an increase of 2.05.
- For Diluted EPS (Rs.), as of Mar 24, the value is 16.55. This value is within the healthy range. It has increased from 14.50 (Mar 23) to 16.55, marking an increase of 2.05.
- For Cash EPS (Rs.), as of Mar 24, the value is 20.93. This value is within the healthy range. It has increased from 20.00 (Mar 23) to 20.93, marking an increase of 0.93.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 56.30. It has increased from 52.43 (Mar 23) to 56.30, marking an increase of 3.87.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 56.30. It has increased from 52.43 (Mar 23) to 56.30, marking an increase of 3.87.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 81.97. It has increased from 77.20 (Mar 23) to 81.97, marking an increase of 4.77.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 22.83. This value is within the healthy range. It has increased from 21.12 (Mar 23) to 22.83, marking an increase of 1.71.
- For PBIT / Share (Rs.), as of Mar 24, the value is 18.57. This value is within the healthy range. It has increased from 15.51 (Mar 23) to 18.57, marking an increase of 3.06.
- For PBT / Share (Rs.), as of Mar 24, the value is 18.20. This value is within the healthy range. It has increased from 15.35 (Mar 23) to 18.20, marking an increase of 2.85.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 16.67. This value is within the healthy range. It has increased from 14.39 (Mar 23) to 16.67, marking an increase of 2.28.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 16.58. This value is within the healthy range. It has increased from 14.50 (Mar 23) to 16.58, marking an increase of 2.08.
- For PBDIT Margin (%), as of Mar 24, the value is 27.84. This value is within the healthy range. It has increased from 27.35 (Mar 23) to 27.84, marking an increase of 0.49.
- For PBIT Margin (%), as of Mar 24, the value is 22.64. This value exceeds the healthy maximum of 20. It has increased from 20.09 (Mar 23) to 22.64, marking an increase of 2.55.
- For PBT Margin (%), as of Mar 24, the value is 22.20. This value is within the healthy range. It has increased from 19.87 (Mar 23) to 22.20, marking an increase of 2.33.
- For Net Profit Margin (%), as of Mar 24, the value is 20.34. This value exceeds the healthy maximum of 10. It has increased from 18.64 (Mar 23) to 20.34, marking an increase of 1.70.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 20.22. This value exceeds the healthy maximum of 20. It has increased from 18.77 (Mar 23) to 20.22, marking an increase of 1.45.
- For Return on Networth / Equity (%), as of Mar 24, the value is 29.57. This value is within the healthy range. It has increased from 27.77 (Mar 23) to 29.57, marking an increase of 1.80.
- For Return on Capital Employeed (%), as of Mar 24, the value is 32.14. This value is within the healthy range. It has increased from 28.68 (Mar 23) to 32.14, marking an increase of 3.46.
- For Return On Assets (%), as of Mar 24, the value is 22.06. This value is within the healthy range. It has increased from 20.56 (Mar 23) to 22.06, marking an increase of 1.50.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.02. This value is within the healthy range. It has decreased from 0.03 (Mar 23) to 0.02, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 1.12. It has increased from 1.00 (Mar 23) to 1.12, marking an increase of 0.12.
- For Current Ratio (X), as of Mar 24, the value is 1.87. This value is within the healthy range. It has increased from 1.78 (Mar 23) to 1.87, marking an increase of 0.09.
- For Quick Ratio (X), as of Mar 24, the value is 1.44. This value is within the healthy range. It has increased from 1.32 (Mar 23) to 1.44, marking an increase of 0.12.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.36. This value is below the healthy minimum of 4. It has decreased from 2.43 (Mar 23) to 2.36, marking a decrease of 0.07.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 48.26. This value is within the healthy range. It has decreased from 55.18 (Mar 23) to 48.26, marking a decrease of 6.92.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 38.39. This value is within the healthy range. It has decreased from 39.79 (Mar 23) to 38.39, marking a decrease of 1.40.
- For Earning Retention Ratio (%), as of Mar 24, the value is 51.74. This value is within the healthy range. It has increased from 44.82 (Mar 23) to 51.74, marking an increase of 6.92.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 61.61. This value is within the healthy range. It has increased from 60.21 (Mar 23) to 61.61, marking an increase of 1.40.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 99.86. This value is within the healthy range. It has decreased from 126.05 (Mar 23) to 99.86, marking a decrease of 26.19.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 74.54. This value is within the healthy range. It has decreased from 86.90 (Mar 23) to 74.54, marking a decrease of 12.36.
- For Enterprise Value (Cr.), as of Mar 24, the value is 18,339.38. It has increased from 0.00 (Mar 23) to 18,339.38, marking an increase of 18,339.38.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 5.13. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 23) to 5.13, marking an increase of 5.13.
- For EV / EBITDA (X), as of Mar 24, the value is 18.41. This value exceeds the healthy maximum of 15. It has increased from 0.00 (Mar 23) to 18.41, marking an increase of 18.41.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 5.16. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 23) to 5.16, marking an increase of 5.16.
- For Retention Ratios (%), as of Mar 24, the value is 51.73. This value is within the healthy range. It has increased from 44.81 (Mar 23) to 51.73, marking an increase of 6.92.
- For Price / BV (X), as of Mar 24, the value is 7.55. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 23) to 7.55, marking an increase of 7.55.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 5.16. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 23) to 5.16, marking an increase of 5.16.
- For EarningsYield, as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 23) to 0.03, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Emami Ltd:
- Net Profit Margin: 20.34%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 32.14% (Industry Average ROCE: 29.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 29.57% (Industry Average ROE: 22.42%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 74.54
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.44
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 28.9 (Industry average Stock P/E: 50.03)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.02
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 20.34%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Personal Care | Emami Tower, 687, Anandapur, Kolkata West Bengal 700107 | investors@emamigroup.com http://www.emamiltd.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. R S Agarwal | Chairman Emeritus |
| Mr. R S Goenka | Non Executive Chairman |
| Mr. Harsha V Agarwal | Vice Chairman & Mng.Director |
| Mr. Mohan Goenka | Vice Chairman & Whole Time Dir |
| Mr. Sushil K Goenka | Whole Time Director |
| Mrs. Priti A Sureka | Whole Time Director |
| Mr. Prashant Goenka | Whole Time Director |
| Mr. Aditya V Agarwal | Non Executive Director |
| Mr. C K Dhanuka | Independent Director |
| Ms. Mamta Binani | Independent Director |
| Mr. Rajiv Khaitan | Independent Director |
| Ms. Avani V Davda | Independent Director |
| Mr. Anjanmoy Chatterjee | Independent Director |
| Mr. Anjani Kumar Agrawal | Independent Director |
| Mr. Debabrata Sarkar | Independent Director |
| Mr. Anand Rathi | Independent Director |
FAQ
What is the intrinsic value of Emami Ltd?
Emami Ltd's intrinsic value (as of 11 October 2025) is 437.14 which is 19.35% lower the current market price of 542.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹23,671 Cr. market cap, FY2025-2026 high/low of 749/508, reserves of ₹2,651 Cr, and liabilities of 3,525 Cr.
What is the Market Cap of Emami Ltd?
The Market Cap of Emami Ltd is 23,671 Cr..
What is the current Stock Price of Emami Ltd as on 11 October 2025?
The current stock price of Emami Ltd as on 11 October 2025 is 542.
What is the High / Low of Emami Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Emami Ltd stocks is 749/508.
What is the Stock P/E of Emami Ltd?
The Stock P/E of Emami Ltd is 28.9.
What is the Book Value of Emami Ltd?
The Book Value of Emami Ltd is 61.7.
What is the Dividend Yield of Emami Ltd?
The Dividend Yield of Emami Ltd is 1.47 %.
What is the ROCE of Emami Ltd?
The ROCE of Emami Ltd is 32.4 %.
What is the ROE of Emami Ltd?
The ROE of Emami Ltd is 30.2 %.
What is the Face Value of Emami Ltd?
The Face Value of Emami Ltd is 1.00.